News
19h
MarketBeat on MSNIs Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?CompanyOverview|NYSE:LLY] The world’s largest pharmaceutical stock, Eli Lilly and Company (NYSE: LLY), recently had its worst ...
Following President Trump's executive order, the Indian pharmaceutical industry anticipates a surge in unannounced ...
Novo Nordisk stock rose after the Danish pharma giant posted better-than-expected quarterly earnings, but cut its guidance ...
Kick off your morning with Killian Woods’ report on property management firm Clancourt’s warning to Jack Chambers of the ...
Google’s chief health officer Karen DeSalvo announced she will retire this summer. DeSalvo, who likes to introduce herself as ...
Bristol Myers Squibb helmsman Chris Boerner joined a growing list of life sciences leaders announcing major U.S. investments ...
Shares of Eli Lilly (NYSE: LLY) sank after the drugmaker lowered its full-year profit outlook, and a potential headwind to ...
Just four months after Eli Lilly and British biotech Alchemab penned a discovery collaboration, the Big Pharma is licensing ...
22h
Money Talks News on MSNHow Pharmaceutical Tariffs Could Trigger Higher Drug Prices and ShortagesPotential tariffs on imported medications could dramatically increase costs for American consumers and worsen existing drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results